Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Change in Account Payables (2019 - 2025)

Harmony Biosciences Holdings' Change in Account Payables history spans 7 years, with the latest figure at -$8.6 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 369.24% year-over-year to -$8.6 million; the TTM value through Dec 2025 reached $3.9 million, up 173.35%, while the annual FY2025 figure was $3.9 million, 173.35% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$8.6 million at Harmony Biosciences Holdings, down from -$2.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $10.8 million in Q2 2025 and bottomed at -$12.2 million in Q3 2024.
  • The 5-year median for Change in Account Payables is $992000.0 (2021), against an average of $437200.0.
  • The largest YoY upside for Change in Account Payables was 4021.48% in 2024 against a maximum downside of 50529.17% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at -$3.2 million in 2021, then plummeted by 97.07% to -$6.3 million in 2022, then surged by 198.93% to $6.2 million in 2023, then crashed by 48.16% to $3.2 million in 2024, then plummeted by 369.24% to -$8.6 million in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Change in Account Payables are -$8.6 million (Q4 2025), -$2.0 million (Q3 2025), and $10.8 million (Q2 2025).